194 related articles for article (PubMed ID: 32723090)
1. Adipose-Derived Mesenchymal Stem Cells in the Treatment of Diabetic Foot Ulcers: A Review of Preclinical and Clinical Studies.
Álvaro-Afonso FJ; Sanz-Corbalán I; Lázaro-Martínez JL; Kakagia D; Papanas N
Angiology; 2020 Oct; 71(9):853-863. PubMed ID: 32723090
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of preconditioned adipose-derived mesenchymal stem cells with photobiomodulation for the treatment of diabetic foot ulcers: a systematic review.
Amini A; Chien S; Bayat M
Lasers Med Sci; 2022 Apr; 37(3):1415-1425. PubMed ID: 34697696
[TBL] [Abstract][Full Text] [Related]
3. Towards reaching the target: clinical application of mesenchymal stem cells for diabetic foot ulcers.
Dash SN; Dash NR; Guru B; Mohapatra PC
Rejuvenation Res; 2014 Feb; 17(1):40-53. PubMed ID: 24237303
[TBL] [Abstract][Full Text] [Related]
4. Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats.
Shi R; Jin Y; Cao C; Han S; Shao X; Meng L; Cheng J; Zhang M; Zheng J; Xu J; Li M
Stem Cell Res Ther; 2016 Oct; 7(1):155. PubMed ID: 27770835
[TBL] [Abstract][Full Text] [Related]
5. Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial.
Arango-Rodríguez ML; Solarte-David VA; Becerra-Bayona SM; Callegari E; Paez MD; Sossa CL; Vera MEO; Mateus LC; Eduardo Serrano S; Ardila-Roa AK; Viviescas LTG
Cytotherapy; 2022 Oct; 24(10):1035-1048. PubMed ID: 36084965
[TBL] [Abstract][Full Text] [Related]
6. New insights into the treatment of non-healing diabetic foot ulcers.
Vicenti G; Bizzoca D; Caruso I; Nappi VS; Giancaspro G; Carrozzo M; Moretti B
J Biol Regul Homeost Agents; 2018; 32(6 Suppl. 1):15-21. PubMed ID: 30644276
[TBL] [Abstract][Full Text] [Related]
7. [Effects of adipose-derived mesenchymal stem cells from type 2 diabetes mellitus patients on wound healing of pressure ulcers in mice].
Deng CL; Yao YZ; Liu ZY; Wang B; Wang DL; Wei ZR
Zhonghua Shao Shang Za Zhi; 2019 Jan; 35(1):40-47. PubMed ID: 30678400
[TBL] [Abstract][Full Text] [Related]
8. [Effect of different transplantations with bone-marrow derived mesenchymal stem cells on diabetic foot ulcers in rats].
Wan J; Cai Q; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):347-55. PubMed ID: 23645234
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer.
Cao Y; Gang X; Sun C; Wang G
J Diabetes Res; 2017; 2017():9328347. PubMed ID: 28386568
[TBL] [Abstract][Full Text] [Related]
10. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
11. Potential of Allogeneic Adipose-Derived Stem Cell-Hydrogel Complex for Treating Diabetic Foot Ulcers.
Moon KC; Suh HS; Kim KB; Han SK; Young KW; Lee JW; Kim MH
Diabetes; 2019 Apr; 68(4):837-846. PubMed ID: 30679183
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers.
Dama G; Du J; Zhu X; Liu Y; Lin J
Diabetes Res Clin Pract; 2023 Jan; 195():110201. PubMed ID: 36493913
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of honey dressing in the treatment of diabetic foot ulcers: A systematic review and meta-analysis.
Wang C; Guo M; Zhang N; Wang G
Complement Ther Clin Pract; 2019 Feb; 34():123-131. PubMed ID: 30712715
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intramuscular bone marrow-derived mesenchymal stem cell transplantation in the leg for treatment of diabetic foot ulcers in rats].
Wan J; Cai Q; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1730-6. PubMed ID: 23268399
[TBL] [Abstract][Full Text] [Related]
15. Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I/2 safety study.
Uzun E; Güney A; Gönen ZB; Özkul Y; Kafadar İH; Günay M; Mutlu M
Foot Ankle Surg; 2021 Aug; 27(6):636-642. PubMed ID: 32826167
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment.
Lu H; Wu X; Wang Z; Li L; Chen W; Yang M; Huo D; Zeng W; Zhu C
J Surg Res; 2016 Oct; 205(2):464-473. PubMed ID: 27664897
[TBL] [Abstract][Full Text] [Related]
17. The role of stem cells in the treatment of diabetic foot ulcers.
Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W
Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adipose-derived mesenchymal stem cell therapy in the treatment of chronic micro- and macrovascular complications of diabetes.
Mikłosz A; Chabowski A
Diabetes Obes Metab; 2024 Mar; 26(3):793-808. PubMed ID: 38073423
[TBL] [Abstract][Full Text] [Related]
19. Primary wound closure of diabetic foot ulcers by debridement and stitching.
Ahmed ME; Mohammed MS; Mahadi SI
J Wound Care; 2016 Nov; 25(11):650-654. PubMed ID: 27827282
[TBL] [Abstract][Full Text] [Related]
20. Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study.
Roth-Albin I; Mai SHC; Ahmed Z; Cheng J; Choong K; Mayer PV
Can J Diabetes; 2017 Feb; 41(1):26-32. PubMed ID: 27634016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
